An A1C result is a percentage that reflects your average blood sugar over roughly the past two to three months. Below 5.7% is considered normal, 5.7% to 6.4% falls in the prediabetes range, and 6.5% or higher on two separate tests indicates diabetes. Those cutoffs, endorsed by major diabetes organizations worldwide, are the starting point for reading your result, but the number on your lab report carries more nuance than a simple pass-or-fail. What it actually represents, how accurately it tracks your blood sugar, and when it can steer you wrong all depend on factors that many people never hear about.
What the Percentage Actually Measures
Hemoglobin is a protein inside your red blood cells that carries oxygen. When glucose circulates in your bloodstream, some of it sticks to hemoglobin through a slow, continuous chemical reaction. The A1C test measures the fraction of your hemoglobin that has glucose attached. Because red blood cells live for about 120 days, the percentage of hemoglobin that has been “glycated” provides a running average of your blood sugar over the preceding six to eight weeks, weighted more heavily toward the most recent weeks.1PubMed Central. Glycated Hemoglobin This is why A1C doesn’t fluctuate the way a single finger-stick glucose reading does. It won’t spike after a big meal or drop after a morning jog. It’s an average, not a snapshot.
That averaging effect is the test’s greatest strength and its greatest weakness. It tells you about the overall trend but hides the peaks and valleys. Two people could share the same A1C while having very different day-to-day glucose patterns, one holding fairly steady and the other swinging from highs to lows. The number alone doesn’t distinguish between those two scenarios.
Translating A1C Into Everyday Blood Sugar
A percentage can feel abstract. If your A1C is 7%, what does your blood sugar actually look like on a typical day? Researchers developed a formula to convert A1C into an estimated average glucose (eAG), and many lab reports now include it alongside the percentage. The relationship is roughly linear: each one-point increase in A1C corresponds to an increase of about 29 mg/dL in average glucose.2PubMed Central. Translating the A1C assay into estimated average glucose values
Here’s a rough translation for the ranges most people encounter:
- A1C 5.0%: estimated average glucose around 97 mg/dL
- A1C 5.7%: around 117 mg/dL, the lower edge of prediabetes
- A1C 6.5%: around 140 mg/dL, the diagnostic threshold for diabetes
- A1C 7.0%: around 154 mg/dL, the common treatment target
- A1C 8.0%: around 183 mg/dL
- A1C 9.0%: around 212 mg/dL
- A1C 10.0%: around 240 mg/dL
These conversions are estimates derived from the correlation between A1C and continuous glucose monitoring data. The correlation is strong but not perfect, so your actual average may differ by 15 to 20 mg/dL in either direction. Still, seeing an eAG number that maps to the same scale as your home glucose meter can make the result much more intuitive.
Why Each Percentage Point Matters
One of the most influential long-term studies of type 2 diabetes found that each one-percentage-point drop in A1C was linked to a roughly 21% lower risk of diabetes-related complications overall, a 14% lower risk of heart attack, and a 37% lower risk of problems with the eyes, kidneys, and nerves.3BMJ. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) That relationship held across a wide range of A1C values, meaning that going from 9% to 8% mattered just as much as going from 8% to 7%. It also means that even if you can’t reach the textbook target, getting closer still reduces risk in a meaningful way.
For most non-pregnant adults with diabetes, guidelines recommend aiming for an A1C below 7%. But that number is a starting point, not a decree, and your doctor may recommend a different target based on your age, how long you’ve had diabetes, what medications you take, and whether you’re prone to low blood sugar episodes.
Targets Are Not One-Size-Fits-All
A 35-year-old recently diagnosed with type 2 diabetes and no other health problems might be encouraged to push toward an A1C below 6.5%. An 80-year-old on insulin who has had diabetes for decades and has other chronic conditions may have a target closer to 8% or even 8.5%. The reasoning is straightforward: aggressively lowering blood sugar with certain medications carries the risk of hypoglycemia, which in older or frailer adults can lead to falls, confusion, and hospitalization. Guidelines from the American Diabetes Association, the European Diabetes guidelines, and the Diabetes Canada group all recommend adjusting A1C targets according to a person’s functional status, cognitive health, and the medications they’re using.4Age and Ageing. Individualisation of glycaemic management in older people with type 2 diabetes
Pregnancy introduces its own set of considerations. Red blood cell turnover increases during pregnancy, which tends to push A1C slightly lower than it would otherwise be. For women with pre-existing diabetes who become pregnant, a target of 6% to 6.5% is generally recommended, with the acknowledgment that going below 6% may be ideal as long as it doesn’t trigger dangerous drops in blood sugar.5Diabetes Care. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018 Gestational diabetes diagnosed during pregnancy is typically managed with glucose monitoring rather than A1C, because the condition develops too late for A1C to track it meaningfully.
When A1C Can Be Misleading
Anything that changes the lifespan of your red blood cells or alters the structure of hemoglobin can throw off your A1C result. This isn’t a rare edge case; it affects millions of people, and recognizing the possibility is one of the most important things you can take away from reading this article.
Conditions that shorten red blood cell lifespan, such as hemolytic anemias, significant blood loss, or recent blood transfusions, tend to push A1C falsely low because the hemoglobin hasn’t been circulating long enough to accumulate as much glucose.6PubMed Central. Pitfalls in hemoglobin A1c measurement: when results may be misleading You might look well-controlled when your blood sugar has actually been running high. Going the other direction, iron-deficiency anemia can falsely elevate A1C. One study found that iron-deficient individuals had A1C readings averaging around 6.8%, with women showing an even larger elevation, despite having controlled plasma glucose levels.7PubMed Central. Influence of Iron Deficiency Anemia on Hemoglobin A1C Levels in Diabetic Individuals with Controlled Plasma Glucose Levels Iron deficiency is extremely common, especially in women of reproductive age, so this isn’t an obscure concern.
Chronic kidney disease, liver disease, heavy alcohol use, and certain medications can also distort results. If your A1C doesn’t seem to match your home glucose readings or your continuous glucose monitor data, talk to your doctor about whether a confounding condition could be at play.
Hemoglobin Variants and Racial Disparities
Hemoglobin comes in different structural variants, and some of these can interfere with certain laboratory methods used to measure A1C. Sickle cell trait is a major example. A large study of African Americans found that people carrying sickle cell trait had A1C values roughly 0.3 percentage points lower than people without the trait at the same fasting glucose level.8JAMA. Association of Sickle Cell Trait With Hemoglobin A1c in African Americans A difference of 0.3 points may sound small, but it’s enough to potentially miss a diabetes diagnosis or underestimate how well someone’s blood sugar is being managed.
Beyond hemoglobin variants, there’s a persistent and still incompletely understood disparity: at the same measured blood glucose levels, Black individuals tend to have higher A1C values than white individuals. This has been documented in adults and children, in people with and without diabetes, and across multiple large studies. In one analysis, the gap ranged from about 0.13 percentage points in people with normal glucose tolerance to about 0.47 points in those with diabetes, even after adjusting for glucose levels and other characteristics.9PubMed. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies Similar patterns have been observed in children with type 1 diabetes.10Diabetes Care. Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes The disparity appears to exist even at the very onset of type 1 diabetes, before any differences in treatment or self-management could explain it.11PubMed Central. Glucose-independent racial disparity in HbA1c is evident at onset of type 1 diabetes
The practical implication is real. If A1C runs naturally higher in some populations for biological reasons unrelated to glucose, using the same diagnostic cutoffs for everyone could lead to overdiagnosis in some groups or underdiagnosis in others. This is an active area of research with no settled solution yet, but it’s something to be aware of if your A1C seems out of step with your other glucose data.
How A1C Compares to Other Diagnostic Tests
A1C is not the only way to diagnose diabetes. Fasting plasma glucose and the oral glucose tolerance test (OGTT) are the traditional alternatives. These tests don’t always agree with each other. In one comparative study, A1C detected about 70% of newly diagnosed diabetes cases, the OGTT caught about 64%, and fasting glucose caught only about 43%.12PubMed Central. Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test Another study found that A1C sometimes classified people as healthy who actually had prediabetes or even diabetes according to glucose-based criteria, and vice versa.13PubMed Central. The performance of hemoglobin A1c against fasting plasma glucose and oral glucose tolerance test in detecting prediabetes and diabetes
A1C’s main advantage is convenience: it doesn’t require fasting and isn’t affected by what you ate the night before. Its disadvantage is that it’s an indirect measure. It tracks glucose through hemoglobin as an intermediary, which means all the confounders discussed above can interfere. When results are borderline or conflicting, doctors sometimes use a second type of test to confirm.
Continuous Glucose Monitors and the Limits of a Single Number
If you wear a continuous glucose monitor (CGM), you get metrics that A1C cannot provide: time in range (the percentage of the day your glucose stays between 70 and 180 mg/dL), glucose variability, and time below range. These add dimension to the flat average that A1C represents. A CGM-derived metric called the glucose management indicator (GMI) estimates what your A1C “should be” based on your sensor data, and when GMI and actual lab A1C diverge, it’s a signal that something is distorting one or the other.
The gap between these metrics can be clinically important. A case highlighted in one review showed a person with a reasonable-looking GMI of 7.4% but a time in range of only 48%, well below the typical target of 70%. Further inspection revealed wide glucose swings with 15% of the time spent above range and 3% below range.14PubMed Central. Time in range—A new gold standard in type 2 diabetes research? The A1C or GMI alone would have painted a reassuring picture. The full CGM data told a different story. For people who have access to CGM data, it’s worth bringing that information to appointments rather than relying on A1C alone.
When A1C Is Unreliable, What Else Can You Measure?
For people with conditions that make A1C inaccurate, such as sickle cell disease, chronic kidney disease, or hemolytic anemias, alternative blood markers can fill in the gap. Fructosamine measures the glycation of serum proteins (mainly albumin) and reflects glucose control over the previous two to three weeks rather than two to three months. Glycated albumin is a related test that offers a similar shorter window and is particularly useful when red blood cell turnover is abnormal.15PubMed Central. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes Another marker, 1,5-anhydroglucitol (1,5-AG), drops when blood sugar has recently spiked above about 180 mg/dL, making it useful for detecting glucose excursions that A1C would smooth over.16PubMed Central. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
None of these are as widely used or as well standardized as A1C, and they aren’t interchangeable replacements. They work best as complements when A1C is known or suspected to be unreliable. If you have a condition that affects your red blood cells and your A1C seems off, ask whether one of these alternatives would give a clearer picture.
Point-of-Care A1C Tests and At-Home Kits
You may encounter A1C testing done at the point of care, right in the doctor’s office using a desktop analyzer, or through at-home kits that you mail to a lab. These offer faster results than sending blood to a central laboratory, but how reliable are they? Studies evaluating point-of-care devices have found that the best ones track closely with reference laboratory methods, with fingerstick results correlating very strongly with lab values and an average bias of roughly 0.02 percentage points.17PubMed Central. Accuracy and Precision of a Point-of-Care HbA1c Test The total error for fingerstick samples ranged from about 3% to 5%, which is within the performance targets set by professional guidelines.18PubMed Central. Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test
In practical terms, a high-quality point-of-care test is accurate enough for monitoring trends and making treatment decisions. Where it can fall short is in borderline cases. If your result comes back right at 6.5%, the diagnostic threshold, you’ll likely need a confirmatory lab draw before anyone calls it diabetes. And cheaper consumer-grade kits are not always validated to the same standards as the devices used in clinical settings, so it’s worth checking whether the device or lab carries certification from a recognized standardization program.
Dietary Changes and Their Effect on A1C
Because A1C reflects average blood sugar, anything that consistently lowers your daily glucose will eventually bring your A1C down. Among dietary approaches, reducing carbohydrate intake has the most direct effect, since carbohydrates are the macronutrient that raises blood sugar the most. A randomized trial of people with type 2 diabetes or prediabetes found that a low-carbohydrate diet lowered A1C by about 0.23 percentage points more than a usual diet over six months.19JAMA Network Open. Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c Another trial comparing a low-carbohydrate diet to a low-fat diet found that the low-carbohydrate group dropped their A1C by about 0.7 points, even though both groups lost similar amounts of weight, suggesting the carbohydrate reduction itself was doing the work beyond just weight loss.20PubMed Central. Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes
These effects are modest individually, but they compound when combined with exercise, medication adjustments, and sustained behavior changes. Because A1C moves slowly, give any new approach at least two to three months before judging its effect on your next lab result. Checking A1C more often than every three months typically doesn’t reflect meaningful change and can lead to unnecessary anxiety or premature medication adjustments.
The Standardization Behind the Number
One reason A1C results are reliable across different hospitals and labs is a decades-long effort to standardize the assay. Two major standardization systems exist. The NGSP, rooted in the landmark diabetes trials of the 1990s, reports results as a percentage (the format used in the United States and many other countries). The IFCC reference system reports in millimoles per mole (mmol/mol), which you’ll see on lab reports in the UK, much of Europe, and Australia. An international consensus established a master equation to convert between the two, so the same level of glucose control reads the same regardless of which system your lab uses.21PubMed Central. The NGSP: Over 20 Years of Improving HbA1c Measurement
If you see your A1C reported as something like “48 mmol/mol” and aren’t sure what that means, it’s equivalent to 6.5%. An A1C of 7.0% converts to 53 mmol/mol. Most lab reports include both values or clearly label which system they’re using. If you’re comparing results between different countries or different time periods, make sure you’re looking at the same units before concluding your control has changed.
The Emotional Weight of a Number
A1C results can carry a surprising psychological load, especially for people who have been managing diabetes for years. The number can feel like a grade, and a result that comes in higher than expected may trigger guilt, frustration, or shame. Research has found a strong link between diabetes-related stigma and psychological distress, with a pooled correlation of 0.50 across multiple studies, a robust association by any standard.22PubMed Central. The relationship between stigma and psychological distress among people with diabetes When A1C becomes the only metric that seems to matter in a clinical visit, the emotional stakes get even higher.
Many diabetes educators now encourage thinking of A1C as information rather than judgment. A higher number doesn’t mean failure; it means the current strategy needs adjusting, whether that’s medication dosing, meal timing, physical activity, or addressing stress and sleep. If your A1C feels like it dominates your appointments and your self-image, it may help to ask your care team to discuss the full picture, including CGM data, blood pressure, lipids, and how you actually feel, rather than leading every conversation with a single number.